BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37925396)

  • 1. Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country.
    Fathi M; Moradi N; Yousefi N; Peiravian F; Shobeiri N
    BMC Pulm Med; 2023 Nov; 23(1):429. PubMed ID: 37925396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to affordable medicines and diagnostic tests for asthma and COPD in sub Saharan Africa: the Ugandan perspective.
    Kibirige D; Kampiire L; Atuhe D; Mwebaze R; Katagira W; Muttamba W; Nantanda R; Worodria W; Kirenga B
    BMC Pulm Med; 2017 Dec; 17(1):179. PubMed ID: 29216852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affordability of Medication Therapy in Diabetic Patients: A Scenario-Based Assessment in Iran's Health System Context.
    Zarei L; Peymani P; Moradi N; Kheirandish M; Mirjalili M; Zare M
    Int J Health Policy Manag; 2022 Apr; 11(4):443-452. PubMed ID: 32861229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affordability Assessment from a Static to Dynamic Concept: A Scenario-Based Assessment of Cardiovascular Medicines.
    Zarei L; Karimzadeh I; Moradi N; Peymani P; Asadi S; Babar ZU
    Int J Environ Res Public Health; 2020 Mar; 17(5):. PubMed ID: 32151039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
    Ewen M; Zweekhorst M; Regeer B; Laing R
    PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review.
    Stolbrink M; Thomson H; Hadfield RM; Ozoh OB; Nantanda R; Jayasooriya S; Allwood B; Halpin DMG; Salvi S; de Oca MM; Mortimer K; Rylance S
    Lancet Glob Health; 2022 Oct; 10(10):e1423-e1442. PubMed ID: 36113528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria.
    Ozoh OB; Eze JN; Garba BI; Ojo OO; Okorie EM; Yiltok E; Okoli CV; Hammangabdo A; Beran D
    Trop Med Int Health; 2021 Jan; 26(1):54-65. PubMed ID: 32985028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability, pricing and affordability of selected medicines for noncommunicable diseases.
    Heidari E; Varmaghani M; Abdollahiasl A
    East Mediterr Health J; 2019 Oct; 25(7):473-480. PubMed ID: 31612979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
    Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
    J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
    Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
    PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.
    Babar ZU; Lessing C; Mace C; Bissell K
    Pharmacoeconomics; 2013 Nov; 31(11):1063-82. PubMed ID: 24127259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability and affordability of children essential medicines in health facilities of southern nations, nationalities, and people region, Ethiopia: key determinants for access.
    Tadesse T; Abuye H; Tilahun G
    BMC Public Health; 2021 Apr; 21(1):714. PubMed ID: 33849513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology.
    Sisay M; Amare F; Hagos B; Edessa D
    J Pharm Policy Pract; 2021 Jul; 14(1):57. PubMed ID: 34225781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the prices and affordability of oncology medicines for three common cancers within the private sector of South Africa.
    Mattila PO; Babar ZU; Suleman F
    BMC Health Serv Res; 2021 Jul; 21(1):661. PubMed ID: 34229693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Availability and affordability of cardiovascular medicines in a major city of Afghanistan in 2020.
    Kokabisaghi F; Hashemi-Meshkini A; Obewal A; Ghavami V; Javan-Noughabi J; Shabanikiya H; Varmaghani M; Moghri J
    Daru; 2022 Dec; 30(2):343-350. PubMed ID: 36385235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budesonide + formoterol delivered via Spiromax
    Lewis A; Torvinen S; Dekhuijzen PNR; Chrystyn H; Melani A; Zöllner Y; Kolbe K; Watson AT; Blackney M; Plich A
    Respir Med; 2017 Aug; 129():179-188. PubMed ID: 28732829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Availability and affordability of diagnosis and treatment for asthma and COPD in Ouagadougou, Burkina Faso].
    Ouédraogo AR; Boncoungou K; Ouédraogo JCRP; Ouédraogo GA; Kiendrebeogo JA; Sourabie A; Maiga S; Kafando S; Ouédraogo G; Badoum G; Ouédraogo M
    Rev Mal Respir; 2023 May; 40(5):382-390. PubMed ID: 37062632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in access to anti-malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first-line anti-malarials and diagnostics between 2007 and 2018.
    Kibira D; Ssebagereka A; van den Ham HA; Opigo J; Katamba H; Seru M; Reed T; Leufkens HG; Mantel-Teeuwisse AK
    Malar J; 2021 Mar; 20(1):142. PubMed ID: 33691704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring Availability, Prices and Affordability of Ischaemic Heart Disease Medicines in Bangi, Selangor, Malaysia.
    You HW; Tajuddin NSA; Anwar YAS
    Malays J Med Sci; 2019 Sep; 26(5):113-121. PubMed ID: 31728123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Satisfaction and Clinical Outcomes with Budesonide plus Formoterol Spiromax for Asthma and Chronic Obstructive Pulmonary Disease: A Real-World, Observational Trial.
    Gillissen A; Gessner C; Hechenbichler K; Herth FJF; Juenemann R; Kanniess F; Kardos P; Lommatzsch M; Schneidereit R; Windisch W
    Respiration; 2019; 97(4):292-301. PubMed ID: 30391944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.